Cargando…
TRAF6 as a potential target in advanced breast cancer: a systematic review, meta-analysis, and bioinformatics validation
TRAF6 has emerged as a key regulator of breast cancer (BCa). However, the TRAF family constitutes of seven members that exhibit distinct and overlapping functions. To explore which TRAF represents a potential druggable target for BCa treatment, we searched Medline, Web of Science and Scopus for rele...
Autores principales: | Zeng, Feier, Carrasco, Giovana, Li, Boya, Sophocleous, Antonia, Idris, Aymen I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029787/ https://www.ncbi.nlm.nih.gov/pubmed/36944688 http://dx.doi.org/10.1038/s41598-023-31557-0 |
Ejemplares similares
-
JZL184, A Monoacylglycerol Lipase Inhibitor, Induces Bone Loss in a Multiple Myeloma Model of Immunocompetent Mice
por: Marino, Silvia, et al.
Publicado: (2020) -
Combined deficiency of the Cnr1 and Cnr2 receptors protects against age‐related bone loss by osteoclast inhibition
por: Sophocleous, Antonia, et al.
Publicado: (2017) -
TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis
por: Peramuhendige, Prabha, et al.
Publicado: (2018) -
Comparison of Target Recognition by TRAF1 and TRAF2
por: Kim, Chang Min, et al.
Publicado: (2020) -
Different Activation of TRAF4 and TRAF6 in Inflammatory Bowel Disease
por: Shen, Jun, et al.
Publicado: (2013)